Vivos Therapeutics, Inc. (VVOS) DCF Valuation
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Vivos Therapeutics, Inc. (VVOS) Bundle
Looking to assess the intrinsic value of Vivos Therapeutics, Inc.? Our VVOS DCF Calculator integrates real-world data with comprehensive customization features, allowing you to refine your forecasts and enhance your investment choices.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.4 | 13.1 | 16.9 | 16.0 | 13.8 | 14.7 | 15.6 | 16.5 | 17.6 | 18.7 |
| Revenue Growth, % | 0 | 14.68 | 29.23 | -5.1 | -13.87 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 |
| EBITDA | -9.9 | -11.2 | -19.5 | -24.4 | -16.7 | -13.9 | -14.7 | -15.6 | -16.6 | -17.7 |
| EBITDA, % | -86.59 | -86.04 | -115.73 | -152.03 | -120.82 | -94.53 | -94.53 | -94.53 | -94.53 | -94.53 |
| Depreciation | .8 | .7 | .7 | .7 | .6 | .7 | .8 | .8 | .9 | .9 |
| Depreciation, % | 6.59 | 5.49 | 4.34 | 4.17 | 4.5 | 5.02 | 5.02 | 5.02 | 5.02 | 5.02 |
| EBIT | -10.6 | -12.0 | -20.3 | -25.0 | -17.3 | -14.2 | -15.1 | -16.0 | -17.0 | -18.1 |
| EBIT, % | -93.18 | -91.54 | -120.07 | -156.21 | -125.32 | -96.94 | -96.94 | -96.94 | -96.94 | -96.94 |
| Total Cash | .5 | 18.2 | 24.0 | 3.5 | 1.6 | 7.0 | 7.4 | 7.9 | 8.4 | 8.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.0 | 1.5 | 1.7 | .5 | .2 | 1.0 | 1.1 | 1.1 | 1.2 | 1.3 |
| Account Receivables, % | 8.39 | 11.6 | 10.18 | 2.85 | 1.46 | 6.9 | 6.9 | 6.9 | 6.9 | 6.9 |
| Inventories | .3 | .0 | .0 | .0 | .0 | .1 | .1 | .1 | .1 | .1 |
| Inventories, % | 2.32 | 0.000007653313 | 0 | 0 | 0 | 0.46311 | 0.46311 | 0.46311 | 0.46311 | 0.46311 |
| Accounts Payable | 1.1 | .8 | .9 | 1.4 | 2.1 | 1.3 | 1.4 | 1.5 | 1.6 | 1.7 |
| Accounts Payable, % | 9.51 | 5.98 | 5.45 | 8.81 | 15.54 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 |
| Capital Expenditure | -.2 | -.1 | -2.4 | -.9 | -.8 | -.8 | -.9 | -.9 | -1.0 | -1.1 |
| Capital Expenditure, % | -1.54 | -0.92033 | -14.19 | -5.77 | -5.82 | -5.65 | -5.65 | -5.65 | -5.65 | -5.65 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -10.8 | -8.8 | -20.3 | -23.8 | -17.3 | -13.3 | -14.1 | -15.0 | -16.0 | -17.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -10.3 | -8.8 | -22.0 | -22.3 | -16.5 | -15.1 | -14.2 | -15.1 | -16.0 | -17.1 |
| WACC, % | 31.26 | 30.95 | 31.26 | 31.2 | 31.26 | 31.18 | 31.18 | 31.18 | 31.18 | 31.18 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -36.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -17 | |||||||||
| Terminal Value | -60 | |||||||||
| Present Terminal Value | -15 | |||||||||
| Enterprise Value | -52 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | -52 | |||||||||
| Diluted Shares Outstanding, MM | 1 | |||||||||
| Equity Value Per Share | -42.61 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real VVOS financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe how your inputs affect Vivos Therapeutics' valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- 🔍 Real-Life VVOS Financials: Pre-filled historical and projected data for Vivos Therapeutics, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Vivos' intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Vivos' valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the prebuilt Excel template featuring Vivos Therapeutics, Inc. (VVOS) data.
- Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Adjust forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Immediately see the recalculated results, including Vivos Therapeutics, Inc.'s (VVOS) intrinsic value.
- Step 5: Utilize the outputs to make informed investment decisions or create reports.
Why Choose This Calculator for Vivos Therapeutics, Inc. (VVOS)?
- Accurate Data: Up-to-date Vivos Therapeutics financials provide dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: An intuitive design and clear instructions make it accessible for users of all levels.
Who Should Use This Product?
- Healthcare Professionals: Understand the latest advancements in sleep apnea treatment and apply them in practice.
- Researchers: Utilize data from clinical studies to enhance your research on sleep disorders.
- Investors: Evaluate your investment strategies and analyze market performance for Vivos Therapeutics, Inc. (VVOS).
- Analysts: Optimize your evaluations with a customizable financial model tailored for the healthcare sector.
- Patients: Learn about innovative treatment options for sleep apnea and their potential benefits.
What the Template Contains
- Historical Data: Includes Vivos Therapeutics, Inc.’s (VVOS) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Vivos Therapeutics, Inc.’s (VVOS) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital specific to Vivos Therapeutics, Inc. (VVOS).
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions tailored for Vivos Therapeutics, Inc. (VVOS).
- Quarterly and Annual Statements: A complete breakdown of Vivos Therapeutics, Inc.’s (VVOS) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically for Vivos Therapeutics, Inc. (VVOS).